Edelweiss Recently Listed IPO Fund Direct Growth

Fund Overview

Fund Size

₹788 Cr

Expense Ratio

1.09%

ISIN

INF754K01ML4

Minimum SIP

₹100

Exit Load

2.00%

Inception Date

26 Feb 2018

About this fund

Edelweiss Recently Listed IPO Fund Direct Growth is a Equity - Other mutual fund schemes offered by Edelweiss Mutual Fund. This fund has been in existence for 7 years, 1 months and 2 days, having been launched on 26-Feb-18.
As of 27-Mar-25, it has a Net Asset Value (NAV) of ₹25.34, Assets Under Management (AUM) of 788.32 Crores, and an expense ratio of 1.09%.

Edelweiss Recently Listed IPO Fund Direct Growth has given a CAGR return of 14.03% since inception.
The fund's asset allocation comprises around 98.56% in equities, 0.00% in debts, and 1.44% in cash & cash equivalents.
You can start investing in Edelweiss Recently Listed IPO Fund Direct Growth with a SIP of ₹100 or a Lumpsum investment of ₹100.

Performance against Category Average

In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.

1 Year

+6.72%

— (Cat Avg.)

3 Years

+11.07%

— (Cat Avg.)

5 Years

+24.28%

— (Cat Avg.)

Since Inception

+14.03%

— (Cat Avg.)

Portfolio Summaryas of 28th February 2025

Equity	₹776.97 Cr	98.56%
Others	₹11.36 Cr	1.44%

Top Holdings

All Holdings

Equity

Debt & Others

Name	Type	Amount	Holdings
Bharti Hexacom Ltd	Equity	₹39.65 Cr	5.03%
Bajaj Housing Finance Ltd	Equity	₹31.53 Cr	4.00%
Hyundai Motor India Ltd	Equity	₹31.14 Cr	3.95%
Sagility India Ltd	Equity	₹30.54 Cr	3.87%
Jyoti CNC Automation Ltd	Equity	₹28.75 Cr	3.65%
Clearing Corporation Of India Ltd.	Cash - Repurchase Agreement	₹27.6 Cr	3.50%
Premier Energies Ltd	Equity	₹27.07 Cr	3.43%
Vishal Mega Mart Ltd	Equity	₹27.06 Cr	3.43%
Dr Agarwal’s Health Care Ltd	Equity	₹25.67 Cr	3.26%
TBO Tek Ltd	Equity	₹25.54 Cr	3.24%
NTPC Green Energy Ltd	Equity	₹24.44 Cr	3.10%
Aadhar Housing Finance Ltd	Equity	₹23.89 Cr	3.03%
Innova Captab Ltd	Equity	₹23.59 Cr	2.99%
Inventurus Knowledge Solutions Ltd	Equity	₹22.14 Cr	2.81%
Go Digit General Insurance Ltd	Equity	₹21.34 Cr	2.71%
Awfis Space Solutions Ltd	Equity	₹21.12 Cr	2.68%
Swiggy Ltd	Equity	₹21.08 Cr	2.67%
DOMS Industries Ltd	Equity	₹19.21 Cr	2.44%
Azad Engineering Ltd	Equity	₹19.11 Cr	2.42%
Sai Life Sciences Ltd	Equity	₹18.28 Cr	2.32%
Nifty 27-Mar-2025	Equity Index - Future	₹17.71 Cr	2.25%
Cash Offset For Derivatives	Cash - General Offset	₹-17.71 Cr	2.25%
Happy Forgings Ltd	Equity	₹16.86 Cr	2.14%
ACME Solar Holdings Ltd	Equity	₹16.03 Cr	2.03%
Bikaji Foods International Ltd	Equity	₹14.27 Cr	1.81%
Indegene Ltd	Equity	₹12.99 Cr	1.65%
JSW Infrastructure Ltd	Equity	₹12.74 Cr	1.62%
P N Gadgil Jewellers Ltd	Equity	₹12.55 Cr	1.59%
International Gemmological Institute (India) Ltd	Equity	₹11.94 Cr	1.51%
ASK Automotive Ltd	Equity	₹11.26 Cr	1.43%
Bansal Wire Industries Ltd	Equity	₹11.25 Cr	1.43%
Apeejay Surrendra Park Hotels Ltd	Equity	₹10.21 Cr	1.30%
Ceigall India Ltd	Equity	₹10.18 Cr	1.29%
Protean eGov Technologies Ltd	Equity	₹9.89 Cr	1.26%
Ajax Engnrg L	Equity	₹9.84 Cr	1.25%
Kaynes Technology India Ltd	Equity	₹9.53 Cr	1.21%
Emcure Pharmaceuticals Ltd	Equity	₹9.22 Cr	1.17%
Hexaware Technologies Ltd.	Equity	₹9.07 Cr	1.15%
Kross Ltd	Equity	₹8.47 Cr	1.07%
Waaree Energies Ltd	Equity	₹6.98 Cr	0.89%
Unimech Aerospace And Manufacturing Ltd	Equity	₹6.67 Cr	0.85%
Baazar Style Retail Ltd	Equity	₹6.65 Cr	0.84%
Medi Assist Healthcare Services Ltd	Equity	₹6.13 Cr	0.78%
KFin Technologies Ltd	Equity	₹5.96 Cr	0.76%
SAMHI Hotels Ltd	Equity	₹5.75 Cr	0.73%
Jupiter Life Line Hospitals Ltd	Equity	₹5.74 Cr	0.73%
Sanathan Textiles Ltd	Equity	₹5.41 Cr	0.69%
Carraro India Ltd	Equity	₹5.26 Cr	0.67%
Juniper Hotels Ltd	Equity	₹4.9 Cr	0.62%
Gopal Snacks Ltd	Equity	₹4.44 Cr	0.56%
Ecos (India) Mobility & Hospitality Ltd	Equity	₹4.29 Cr	0.54%
Godavari Biorefineries Ltd	Equity	₹4.1 Cr	0.52%
JNK India Ltd	Equity	₹3.72 Cr	0.47%
91 DTB 17042025	Bond - Gov't/Treasury	₹2.98 Cr	0.38%
Dam Capital Advisors Ltd	Equity	₹2.51 Cr	0.32%
Akums Drugs and Pharmaceuticals Ltd	Equity	₹2 Cr	0.25%
Net Receivables/(Payables)	Cash - Collateral	₹-1.5 Cr	0.19%
Concord Biotech Ltd	Equity	₹0.75 Cr	0.09%
Laxmi Dental Ltd	Equity	₹0.37 Cr	0.05%
Stanley Lifestyles Ltd	Equity	₹0.18 Cr	0.02%
Accrued Interest	Cash - Collateral	₹0 Cr	0.00%

Allocation By Market Cap (Equity)

Allocation By Credit Quality (Debt)

AAA

Other Allocation

Equity Sector

Debt & Others

Sector	Amount	Holdings
Consumer Cyclical	₹175.45 Cr	22.26%
Healthcare	₹157.41 Cr	19.97%
Industrials	₹152.19 Cr	19.30%
Financial Services	₹79.27 Cr	10.06%
Technology	₹49.91 Cr	6.33%
Utilities	₹40.46 Cr	5.13%
Communication Services	₹39.65 Cr	5.03%
Basic Materials	₹27.29 Cr	3.46%
Consumer Defensive	₹18.71 Cr	2.37%

Risk & Performance Ratios

Fund Managers

Bhavesh Jain

Since February 2018

Bharat Lahoti

Since February 2018

Additional Scheme Detailsas of 28th February 2025

ISIN

INF754K01ML4

Expense Ratio

1.09%

Exit Load

2.00%

Fund Size

₹788 Cr

Age

7 years 1 month

Lumpsum Minimum

₹100

Fund Status

Open Ended Investment Company

Benchmark

Nifty IPO TR INR

Investment Objective

To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.

Tax Treatment

Capital Gains Taxation:

Dividend Taxation:

Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.

Similar Equity - Other Funds

Fund name	Expense Ratio	Exit Load	Fund size	1Y
SBI Equity Minimum Variance Fund Direct Growth Very High Risk	0.4%	0.0%	₹197.90 Cr	2.1%
SBI Equity Minimum Variance Fund Regular Growth Very High Risk	0.7%	0.0%	₹197.90 Cr	1.8%
Bandhan Transportation and Logistics Fund Direct Growth Very High Risk	0.9%	0.0%	₹476.44 Cr	3.1%
Bandhan Transportation and Logistics Fund Regular Growth Very High Risk	2.4%	0.0%	₹476.44 Cr	1.6%
ICICI Prudential Transportation and Logistics Fund Direct Growth Very High Risk	0.7%	1.0%	₹2739.18 Cr	7.7%
ICICI Prudential Transportation and Logistics Fund Regular Growth Very High Risk	2.0%	1.0%	₹2739.18 Cr	6.5%
HDFC NIFTY200 Momentum 30 ETF Very High Risk	0.3%	-	₹11.35 Cr	63.0%
HDFC NIFTY100 Low Volatility 30 ETF Very High Risk	0.3%	-	₹5.95 Cr	34.7%
ICICI Prudential Nifty 200 Momentum 30 ETF Very High Risk	0.3%	-	₹397.64 Cr	-6.5%
DSP Nifty Midcap 150 Quality 50 ETF Very High Risk	0.3%	-	₹93.15 Cr	9.1%

About the AMC

Edelweiss Mutual Fund

+91 22 40979900

https://www.edelweissmf.com/

Total AUM

₹1,62,815 Cr

Address

J.P.Morgan Tower, Mumbai, 400 098

Other Funds by Edelweiss Mutual Fund

Fund name	Expense Ratio	Exit Load	Fund size	1Y
Edelweiss Multi Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹2316.38 Cr	12.4%
Edelweiss Banking and PSU Debt Fund Direct Growth Moderate Risk	0.4%	0.0%	₹261.78 Cr	8.6%
Edelweiss NIFTY Large Midcap 250 Index Fund Direct Growth Very High Risk	0.2%	0.0%	₹217.80 Cr	8.1%
Edelweiss Money Market Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹1378.11 Cr	7.8%
Edelweiss Liquid Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹6265.43 Cr	7.4%
Edelweiss Mid Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹7729.29 Cr	20.2%
Edelweiss Greater China Equity Direct Growth Very High Risk	1.4%	1.0%	₹1901.23 Cr	24.1%
Edelweiss ASEAN Equity Off Shore Direct Growth Very High Risk	1.6%	1.0%	₹102.15 Cr	11.2%
Edelweiss Large & Mid Cap Fund Direct Growth Very High Risk	0.5%	1.0%	₹3333.72 Cr	12.1%
Edelweiss CRISIL PSU Plus SDL 50:50 Oct 2025 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹812.86 Cr	7.5%
Edelweiss Europe Dynamic Equity Offshore Fund Direct Growth Very High Risk	1.5%	1.0%	₹107.09 Cr	13.1%
BHARAT Bond FOF April 2030 Direct Growth Moderate Risk	0.1%	0.0%	₹6968.02 Cr	8.6%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Sep 2028 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹153.96 Cr	8.8%
Edelweiss Flexi Cap Fund Direct Growth Very High Risk	0.5%	1.0%	₹2208.81 Cr	12.6%
Edelweiss Overnight Fund Direct Growth Low to Moderate Risk	0.1%	0.0%	₹372.76 Cr	6.6%
Edelweiss Multi Asset Allocation Fund Direct Growth Low to Moderate Risk	0.4%	0.0%	₹1547.35 Cr	8.5%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹151.99 Cr	13.5%
Edelweiss Long Term Equity Fund Direct Growth Very High Risk	0.8%	0.0%	₹352.27 Cr	10.0%
Edelweiss Recently Listed IPO Fund Direct Growth Very High Risk	1.1%	2.0%	₹788.32 Cr	6.7%
Edelweiss Balanced Advantage Fund Direct Growth Very High Risk	0.5%	1.0%	₹11696.63 Cr	8.4%
Edelweiss Government Securities Fund Direct Growth Moderate Risk	0.5%	0.0%	₹171.16 Cr	9.4%
Edelweiss Small Cap Fund Direct Growth Very High Risk	0.4%	1.0%	₹3718.61 Cr	9.0%
Edelweiss Nifty Smallcap 250 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹92.17 Cr	5.8%
Edelweiss Nifty Midcap150 Momentum 50 Index Fund Direct Growth Very High Risk	0.5%	0.0%	₹695.96 Cr	4.9%
Edelweiss Nifty Next 50 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹101.76 Cr	6.3%
Edelweiss Large Cap Fund Direct Growth Very High Risk	0.6%	1.0%	₹1058.57 Cr	8.7%
Edelweiss Aggressive Hybrid Fund Direct Growth Very High Risk	0.3%	1.0%	₹2289.86 Cr	13.0%
Edelweiss Focused Equity Fund Direct Growth Very High Risk	0.7%	1.0%	₹837.88 Cr	12.5%
Edelweiss Nifty PSU Bond Plus SDL Apr 2027 50:50 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹2299.44 Cr	8.1%
BHARAT Bond FOF April 2025 Direct Growth Low to Moderate Risk	0.1%	0.0%	₹4116.11 Cr	8.0%
BHARAT Bond FOF April 2031 Direct Growth Moderate Risk	0.1%	0.0%	₹4716.24 Cr	8.2%
Edelweiss Arbitrage Fund Direct Growth Low Risk	0.4%	0.0%	₹13644.25 Cr	7.9%
Edelweiss Emerging Markets Opportunities Equity Offshore Direct Growth Very High Risk	1.5%	1.0%	₹119.21 Cr	10.0%
Edelweiss US Technology Equity Fund of Fund Direct Growth Very High Risk	1.5%	1.0%	₹2816.32 Cr	9.1%
BHARAT Bond ETF FOF - April 2033 Direct Growth Moderate Risk	0.1%	0.0%	₹2341.30 Cr	8.3%
Edelweiss Gold and Silver ETF Fund of Fund Direct Growth Very High Risk	0.1%	0.0%	₹256.40 Cr	31.3%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL June 2027 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹91.62 Cr	8.3%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL Short Duration Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹152.59 Cr	8.5%
Edelweiss Nifty 50 Index Fund Direct Growth Very High Risk	0.1%	0.0%	₹135.88 Cr	7.6%
Edelweiss Nifty 100 Quality 30 Index Fund Direct Growth Very High Risk	0.3%	0.0%	₹143.01 Cr	4.8%
Edelweiss CRISIL IBX 50:50 Gilt Plus SDL April 2037 Index Fund Direct Growth Moderate Risk	0.2%	0.0%	₹1004.58 Cr	10.8%
BHARAT Bond ETF FOF - April 2032 Direct Growth Moderate Risk	0.1%	0.0%	₹4461.93 Cr	8.7%
Edelweiss Nifty PSU Bond Plus SDL Apr 2026 50:50 Index Fund Direct Growth Low to Moderate Risk	0.2%	0.0%	₹7648.23 Cr	7.8%
Edelweiss US Value Equity Offshore Fund Direct Growth Very High Risk	1.4%	1.0%	₹180.66 Cr	11.7%
Edelweiss Equity Savings Fund Direct Growth Moderate Risk	0.6%	0.0%	₹568.54 Cr	10.8%

Risk Level

Your principal amount will be at Very High Risk

Take control of your wealth

Track and Analyse all your investments with Wealth Monitor

Rated ★ 4.3+ on

Still got questions?
We're here to help.

What is the current NAV of Edelweiss Recently Listed IPO Fund Direct Growth?

The NAV of Edelweiss Recently Listed IPO Fund Direct Growth, as of 27-Mar-2025, is ₹25.34.

What are the returns of Edelweiss Recently Listed IPO Fund Direct Growth?

The fund has generated 6.72% over the last 1 year and 11.07% over the last 3 years. However, this does not guarantee that the fund will perform similarly in the future.

What is the portfolio composition of Edelweiss Recently Listed IPO Fund Direct Growth?

The fund's allocation of assets is distributed as 98.56% in equities, 0.00% in bonds, and 1.44% in cash and cash equivalents.

Who manages the Edelweiss Recently Listed IPO Fund Direct Growth?

The fund managers responsible for Edelweiss Recently Listed IPO Fund Direct Growth are:-

Bhavesh Jain
Bharat Lahoti

Disclaimer: Mutual Fund investments are subject to market risks, read all scheme-related documents carefully. The NAVs of the schemes may go up or down depending upon the factors and forces affecting the securities market including the fluctuations in the interest rates. The past performance of the mutual funds is not necessarily indicative of the future performance of the schemes. Investors are requested to review the prospectus carefully and obtain expert professional advice with regard to specific legal, tax and financial implications of the investment/participation in the scheme.

;

Fund Overview

Fund Size

₹788 Cr

Expense Ratio

1.09%

ISIN

INF754K01ML4

Minimum SIP

₹100

Exit Load

2.00%

Inception Date

26 Feb 2018

Risk Level

Your principal amount will be at Very High Risk